Join us for a one-hour scientific webinar exploring current perspectives on skin-directed therapies for patients with early-stage mycosis fungoides (MF-CTCL).

The program will begin with a review of key clinical highlights from the 2026 EORTC-CLTG Annual Meeting in Berlin, presented by Prof. Chalid Assaf. This will be followed by Prof. Maarten Vermeer, who will share translational research insights into the tumour microenvironment and its relevance for disease understanding and future therapeutic approaches.

The webinar will conclude with a live Q&A session, providing you with the opportunity to engage directly with the faculty.